Archean Chemical Industries Share Price
Sector:
663.00 +9.95 (1.52%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
638.00
Today’s High
667.80
52 Week Low
409.00
52 Week High
831.00
663.15 +6.45 (0.98%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
636.50
Today’s High
667.50
52 Week Low
408.35
52 Week High
832.00
Key Metrics
- Market Cap (In Cr) 8183.25
- Beta -
- Div. Yield (%) 0.15
- P/B 4.76
- TTM P/E 49.67
- Peg Ratio -
- Sector P/E 17.96
- Open Price 650.45
- Prev Close 653.05
Archean Chemical Industries Analysis
Price Analysis
-
1 Week2.83%
-
3 Months16.11%
-
6 Month10.03%
-
YTD-1.92%
-
1 Year-3.34%
Risk Meter
- 47% Low risk
- 47% Moderate risk
- 47% Balanced Risk
- 47% High risk
- 47% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 4
- 4
- 3
- 3
- Buy
- 0.00
- 0.00
- 1
- 1
- Hold
- 0.00
- 0.00
- 0.00
- 0.00
- Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Strong Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Total
- 4
- 4
- 4
- 4
Archean Chemical Industries News
Buy or sell: Vaishali Parekh recommends three stocks to buy today — 8 April 2025
2 min read . 08 Apr 2025Goldman Sachs-owned, DII favourite small-cap stock drops 6% to hit record low
2 min read . 13 Feb 2025Stocks to buy: Navin Fluorine, SRF among top 5 chemical stock picks
3 min read . 20 Jun 2024P&G Health, Sumitomo Chemical, Minda Corp among 7 stocks to trade ex-dividend
1 min read . 14 Feb 2024Archean Chemical Industries Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 1330.09
- Selling/ General/ Admin Expenses Total
- 681.02
- Depreciation/ Amortization
- 70.34
- Total Operating Expense
- 937.73
- Operating Income
- 392.36
- Net Income Before Taxes
- 427.18
- Net Income
- 318.98
- Diluted Normalized EPS
- 25.87
- Period
- 2024
- Total Assets
- 2055.86
- Total Liabilities
- 354.31
- Total Equity
- 1701.55
- Tangible Book Valueper Share Common Eq
- 137.72
- Period
- 2024
- Cashfrom Operating Activities
- 379.35
- Cashfrom Investing Activities
- -307.27
- Cashfrom Financing Activities
- -32.57
- Net Changein Cash
- 39.51
- Period
- 2023
- Total Revenue
- 1441.07
- Selling/ General/ Admin Expenses Total
- 804.34
- Depreciation/ Amortization
- 68.63
- Total Operating Expense
- 875.7
- Operating Income
- 565.36
- Net Income Before Taxes
- 511.68
- Net Income
- 382.56
- Diluted Normalized EPS
- 34.58
- Period
- 2023
- Total Assets
- 1755.43
- Total Liabilities
- 324.41
- Total Equity
- 1431.02
- Tangible Book Valueper Share Common Eq
- 116.28
- Period
- 2023
- Cashfrom Operating Activities
- 496.09
- Cashfrom Investing Activities
- -290.35
- Cashfrom Financing Activities
- -211.97
- Net Changein Cash
- -6.23
- Period
- 2022
- Total Revenue
- 1130.44
- Selling/ General/ Admin Expenses Total
- 623.96
- Depreciation/ Amortization
- 66.88
- Total Operating Expense
- 730.16
- Operating Income
- 400.27
- Net Income Before Taxes
- 250.99
- Net Income
- 188.58
- Diluted Normalized EPS
- 15.32
- Period
- 2022
- Total Assets
- 1531.31
- Total Liabilities
- 1269.03
- Total Equity
- 262.29
- Tangible Book Valueper Share Common Eq
- 21.3
- Period
- 2022
- Cashfrom Operating Activities
- 314.52
- Cashfrom Investing Activities
- -110.11
- Cashfrom Financing Activities
- -223.72
- Net Changein Cash
- -19.31
- Period
- 2020
- Total Revenue
- 608.17
- Selling/ General/ Admin Expenses Total
- 459.36
- Depreciation/ Amortization
- 51.76
- Total Operating Expense
- 511.95
- Operating Income
- 96.23
- Net Income Before Taxes
- -16.69
- Net Income
- -36.22
- Diluted Normalized EPS
- -2.93
- Period
- 2020
- Total Assets
- 1428.62
- Total Liabilities
- 1422.63
- Total Equity
- 5.99
- Tangible Book Valueper Share Common Eq
- 0.48
- Period
- 2020
- Cashfrom Operating Activities
- 147.55
- Cashfrom Investing Activities
- -196.67
- Cashfrom Financing Activities
- 26.36
- Net Changein Cash
- -22.76
- Period
- 2024-12-31
- Total Revenue
- 242.29
- Selling/ General/ Admin Expenses Total
- 13.9
- Depreciation/ Amortization
- 20.14
- Other Operating Expenses Total
- 164.25
- Total Operating Expense
- 182.49
- Operating Income
- 59.8
- Net Income Before Taxes
- 65.75
- Net Income
- 47.82
- Diluted Normalized EPS
- 3.89
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 240.46
- Selling/ General/ Admin Expenses Total
- 12.84
- Depreciation/ Amortization
- 19.46
- Other Operating Expenses Total
- 139.2
- Total Operating Expense
- 225.38
- Operating Income
- 15.07
- Net Income Before Taxes
- 22.78
- Net Income
- 15.78
- Diluted Normalized EPS
- 3.5
- Period
- 2024-09-30
- Total Assets
- 2158.22
- Total Liabilities
- 394.65
- Total Equity
- 1763.57
- Tangible Book Valueper Share Common Eq
- 142.75
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 77.02
- Cashfrom Investing Activities
- -113.99
- Cashfrom Financing Activities
- 36.96
- Net Changein Cash
- -0.02
- Period
- 2024-06-30
- Total Revenue
- 212.69
- Selling/ General/ Admin Expenses Total
- 14.72
- Depreciation/ Amortization
- 18.64
- Other Operating Expenses Total
- 144.81
- Total Operating Expense
- 160.13
- Operating Income
- 52.56
- Net Income Before Taxes
- 60.56
- Net Income
- 44.86
- Diluted Normalized EPS
- 3.63
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 283.91
- Selling/ General/ Admin Expenses Total
- 14.67
- Depreciation/ Amortization
- 17.67
- Other Operating Expenses Total
- 190.02
- Total Operating Expense
- 214.45
- Operating Income
- 69.46
- Net Income Before Taxes
- 79.72
- Net Income
- 57.59
- Diluted Normalized EPS
- 4.66
- Period
- 2024-03-31
- Total Assets
- 2055.86
- Total Liabilities
- 354.31
- Total Equity
- 1701.55
- Tangible Book Valueper Share Common Eq
- 137.72
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 379.35
- Cashfrom Investing Activities
- -307.27
- Cashfrom Financing Activities
- -32.57
- Net Changein Cash
- 39.51
- Period
- 2023-12-31
- Total Revenue
- 412.63
- Selling/ General/ Admin Expenses Total
- 18.22
- Depreciation/ Amortization
- 17.66
- Other Operating Expenses Total
- 202.01
- Total Operating Expense
- 284.84
- Operating Income
- 127.78
- Net Income Before Taxes
- 135.13
- Net Income
- 101.53
- Diluted Normalized EPS
- 8.23
- Period
- 2023-12-31
- Period
- 2023-12-31
- Period
- 2023-09-30
- Total Revenue
- 290.46
- Selling/ General/ Admin Expenses Total
- 19.2
- Depreciation/ Amortization
- 17.5
- Other Operating Expenses Total
- 157.04
- Total Operating Expense
- 212.51
- Operating Income
- 77.95
- Net Income Before Taxes
- 87.29
- Net Income
- 66
- Diluted Normalized EPS
- 5.34
- Period
- 2023-09-30
- Total Assets
- 1882.99
- Total Liabilities
- 313.08
- Total Equity
- 1569.91
- Tangible Book Valueper Share Common Eq
- 127.57
- Period
- 2023-09-30
- Cashfrom Operating Activities
- 211.91
- Cashfrom Investing Activities
- -152.57
- Cashfrom Financing Activities
- -34.42
- Net Changein Cash
- 24.92
- Period
- 2023-06-30
- Total Revenue
- 343.09
- Selling/ General/ Admin Expenses Total
- 20.34
- Depreciation/ Amortization
- 17.51
- Other Operating Expenses Total
- 158.26
- Total Operating Expense
- 225.97
- Operating Income
- 117.13
- Net Income Before Taxes
- 125.04
- Net Income
- 93.86
- Diluted Normalized EPS
- 7.6
- Period
- 2023-06-30
- Period
- 2023-06-30
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Archean Chemical Industries Technical
Moving Average
SMA
- 5 Day640.78
- 10 Day627.02
- 20 Day577.64
- 50 Day537.72
- 100 Day587.45
- 300 Day646.3
Archean Chemical Industries Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Netweb Technologies India
- 1463.65
- 5.4
- 0.37
- 3060
- 1278.85
- 8292.14
- Akums Drugs And Pharmaceuticals
- 526
- -4.6
- -0.87
- 1174.85
- 407.4
- 8268.02
- Archean Chemical Industries
- 663
- 9.95
- 1.52
- 831
- 409
- 8183.25
- Ask Automotive
- 407
- -1.75
- -0.43
- 508.95
- 285.25
- 8023.7
- Bharat Global Developers
- 740.5
- -38.95
- -5
- 1702.95
- 135.25
- 7498.27
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Netweb Technologies India
- 100.71
- 19.46
- -
- -
- Akums Drugs And Pharmaceuticals
- 642.24
- 11.77
- -
- -
- Archean Chemical Industries
- 25.38
- 4.76
- -
- -
- Ask Automotive
- 46.32
- 9.85
- -
- -
- Bharat Global Developers
- 2286.58
- 75.41
- -
- -
Archean Chemical Industries Shareholding
Shareholding Pattern
*Promoter pledging: 3.73%
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 02-May-25
- Audited Results & Final Dividend
- 07-Feb-25
- Quarterly Results
- 08-Nov-24
- Quarterly Results
- 02-Aug-24
- Quarterly Results
- 14-May-24
- Audited Results & Final Dividend
- 03-Feb-24
- Quarterly Results & Interim Dividend
- 31-Oct-23
- Quarterly Results & Interim Dividend
- 11-Aug-23
- Quarterly Results
- 26-May-23
- Audited Results & Final Dividend
- 10-Feb-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 28-Jun-24
- 14-May-24
- AGM
- 17-Nov-23
- 17-Oct-23
- POM
- 26-Jul-23
- 26-May-23
- AGM
- 11-Jul-23
- 06-Jun-23
- POM
- 28-Mar-23
- 22-Feb-23
- POM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 14-May-24
- 21-Jun-24
- 21-Jun-24
- 1
- 05-Feb-24
- 14-Feb-24
- 14-Feb-24
- 1
- 31-Oct-23
- 17-Nov-23
- 17-Nov-23
- 1
- 26-May-23
- 21-Jul-23
- 21-Jul-23
- 2.5


